Telomir Pharmaceuticals Inc (NASDAQ: TELO) Stock Sentiment: What’s Wall Street Saying?

AMAT

Telomir Pharmaceuticals Inc (NASDAQ:TELO) price closed lower on Tuesday, July 22, and dropping -4.98% below its previous close.

A look at the daily price movement shows that the last close reads $2.21, with intraday deals fluctuated between $2.03 and $2.23. Taking into account the 52-week price action we note that the stock hit a 52-week high of $8.40 and 52-week low of $1.12. The stock added 19.32% on its value in the past month.

Telomir Pharmaceuticals Inc, which has a market valuation of $62.51 million, is expected to release its quarterly earnings report on 2025-May-14.

Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TELO a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.

The overview shows that TELO’s price is at present 46.37% off the SMA20 and 13.05% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 64.75, with weekly volatility standing at 16.28%. The indicator jumps to 10.16% when calculated based on the past 30 days. Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s beta value is holding at -0.78.

An analysis of the Telomir Pharmaceuticals Inc (NASDAQ:TELO) stock in terms of its daily trading volume indicates that the 3-month average is 3.03 million. However, this figure increases on the past 10-day timeline to an average of 17.52 million.

Current records show that the company has 29.76M in outstanding shares. The insiders’ percentage holdings are 42.03% of outstanding shares while the percentage share held by institutions stands at 12.40%. The stats also highlight that short interest as of 2025-06-30, stood at 1.45 million shares, which puts the short ratio at the time at 3.47. From this we can glean that short interest is 740.00 of company’s current outstanding shares. Notably, we see that shares short in June fall slightly given the previous month’s figure stood at 2.29 million. But the -46.02% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.